Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer

Modified FOLFIRINOX (mFFX) and Gemcitabine plus nab-paclitaxel (GnP) are effective first-line chemotherapies for unresectable advanced pancreatic cancer (APC); however, both lead to peripheral neuropathy (PN). Aims: To evaluate the impact of first-line mFFX-induced PN on the efficacy of second-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadaka, Shiori, Iwashita, Takuji, Fujii, Hironori, Kato-Hayashi, Hiroko, Ohata, Koichi, Uemura, Shinya, Shimizu, Masahito, Suzuki, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572211/
https://www.ncbi.nlm.nih.gov/pubmed/36233762
http://dx.doi.org/10.3390/jcm11195895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572211/
https://www.ncbi.nlm.nih.gov/pubmed/36233762
http://dx.doi.org/10.3390/jcm11195895

Ejemplares similares